Keyphrases
Aberrations
16%
Acetylated Histone
16%
Aggresome
16%
Angiogenesis Inhibition
16%
Anti-apoptotic Factor
16%
Anticancer Drugs
100%
Anticancer Properties
16%
Apoptosis
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Cancer Cell Lines
16%
Cancer Cells
33%
Cancer Knowledge
16%
Cancer Therapeutics
16%
Caspase 3/7 Activity
16%
Cell Cycle Arrest
16%
Cell Cycle Proteins
16%
Cell Death
100%
Cellular Stress
100%
Clinical Efficacy
100%
Cytotoxicity
16%
Endoplasmic Reticulum
16%
Epigenetic Mechanisms
16%
Epigenetic Signal
100%
Gene Expression
16%
Histone Acetylation
16%
Histone Acetyltransferase
16%
Histone Deacetylase Inhibitor (HDACi)
33%
Histone Epigenetics
16%
Histone Modification
16%
Hydroxamic Acid
16%
Immune Regulation
16%
In Cancer
16%
Inhibitory Effect
16%
Interferon Receptor
16%
Intrinsic Mechanism
16%
Lactate
16%
Large B-cell Lymphoma
16%
LBH589
16%
Modification Mechanism
16%
Molecular Mechanism
100%
Multiple Signaling Pathways
16%
Nanomolar Level
16%
New Therapeutics
16%
Non-selective
16%
Orally Bioavailable
16%
Panobinostat
100%
Poly(ADP-ribose) Polymerase
16%
Pro-apoptotic Factors
16%
Programmed Death-ligand 1 (PD-L1)
16%
Stochasticity
100%
Subpath
16%
Therapeutic Outcome
16%
Therapeutic Perspectives
16%
Tumor Microenvironment Remodeling
16%
Tumorigenesis
16%
Medicine and Dentistry
Aggresome
12%
Alternative Complement Pathway C3 C5 Convertase
12%
Antiangiogenic Activity
12%
Antiapoptotic
12%
Anticancer Drug
100%
B-Cell Lymphoma
25%
Cancer Cell
25%
Cancer Cell Line
12%
Carcinogenesis
12%
Caspase 3
12%
Cell Cycle Arrest
12%
Cell Cycle Checkpoint
12%
Cell Cycle Protein
12%
Cell Death
100%
Cell Signaling Pathway
12%
Cell Stress
100%
Cytotoxicity
12%
Endoplasmic reticulum
12%
Epigenetic Mechanism
12%
Gamma Interferon Receptor 1
12%
Gene Expression
12%
Histone
12%
Histone Acetylation
12%
Histone Acetyltransferase
12%
Histone Deacetylase Inhibitor
12%
Histone Modification
12%
Hydroxamic Acid
12%
Immune Response
12%
Malignant Neoplasm
25%
P21
12%
Panobinostat
100%
Poly ADP Ribose Polymerase
12%
Programmed Cell Death
12%
Programmed Death 1 Ligand 1
12%
Proteasome
12%
Sensitization
100%
Tumor Microenvironment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
12%
Antiapoptotic
12%
Anticancer Drug
100%
B Cell Lymphoma
25%
Carcinogenesis
12%
Caspase 3
12%
Cell Cycle Protein
12%
Cytotoxicity
12%
Gamma Interferon Receptor 1
12%
Histone
37%
Histone Acetyltransferase
12%
Histone Deacetylase Inhibitor
12%
Hydroxamic Acid
12%
Malignant Neoplasm
62%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
12%
Panobinostat
100%
Programmed Death 1 Ligand 1
12%
Proteasome
12%
Tumor Microenvironment
12%